WallStreetZenWallStreetZen

NASDAQ: ABOS
Acumen Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ABOS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$52.4M
Current Profit Margin
0%

ABOS Return on Equity

Current Company
-23.4%
Current Industry
-63.5%
Current Market
188%
ABOS's Return on Equity (-23.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ABOS announces earnings.

ABOS Return on Assets

Current Company
-21.8%
Current Industry
2.9%
ABOS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ABOS Return on Capital Employed

Current Company
-17.43%
Current Industry
19.5%
ABOS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABOS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABOS$0.00-$51.61M-$52.37MN/AN/A
INMB$155.00k-$30.01M-$30.01M+235.68%N/A
IPSC$2.24M-$122.40M-$136.67M-57.01%N/A
VERU$15.93M-$62.11M-$64.59M-4.11%N/A
ELEV$0.00-$45.64M-$45.70MN/AN/A
View Top Biotech Stocks

ABOS earnings dates

Next earnings date
May 6, 2024

Acumen Pharmaceuticals Earnings & Revenue FAQ

What were ABOS's earnings last quarter?

On Invalid Date, Acumen Pharmaceuticals (NASDAQ: ABOS) reported Q4 2023 earnings per share (EPS) of -$0.29, up 9.38% year over year. Total Acumen Pharmaceuticals earnings for the quarter were -$16.50 million. In the same quarter last year, Acumen Pharmaceuticals's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.

What was ABOS's earnings growth in the past year?

As of Q2 2024, Acumen Pharmaceuticals's earnings has grown year over year. Acumen Pharmaceuticals's earnings in the past year totalled -$52.37 million.

What is ABOS's earnings date?

Acumen Pharmaceuticals's earnings date is Invalid Date. Add ABOS to your watchlist to be reminded of ABOS's next earnings announcement.

What was ABOS's revenue last quarter?

On Invalid Date, Acumen Pharmaceuticals (NASDAQ: ABOS) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Acumen Pharmaceuticals's revenue was $0.00.

What was ABOS's revenue growth in the past year?

As of Q2 2024, Acumen Pharmaceuticals's revenue has grown null year over year. Acumen Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.